Fosun Pharma to Buy Majority Stake in Hongqi Pharma

Shanghai Fosun Pharmaceutical will acquire a 70% stake in Shenyang Hongqi Pharmaceutical, a company focused on tuberculosis treatments. Fosun will attempt to increase penetration of Hongqi’s TB drugs in the international market. Financial terms of the transaction were not disclosed. More details.... Stock Symbol: (SHEX: 600196)